In vivo models bring FSP1 inhibitors to life Dec 13 Written by Thales Papagiannakopoulos News and Views by Olzmann lab about our groups recent study on targeting FSP1 to promote ferroptosis in cancer Thales Papagiannakopoulos Previous Previous PapaG Lab is part of newly funded Cancer Grand Challenges InteroCANCEption Team Next Next Dr. Papagiannakopoulos The Scientist webinar about Cell Signaling and Metabolism
In vivo models bring FSP1 inhibitors to life Dec 13 Written by Thales Papagiannakopoulos News and Views by Olzmann lab about our groups recent study on targeting FSP1 to promote ferroptosis in cancer Thales Papagiannakopoulos